NCT00226447View on ClinicalTrials.gov

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Chronic Hepatitis B

Interventions

DRUG

Pegylated Interferon

DRUG

Lamivudine

Trial Locations (1)

Unknown

Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Chinese University of Hong Kong

OTHER